申请人:Van Zandt Michael C.
公开号:US20090082392A1
公开(公告)日:2009-03-26
The present invention relates to compounds and pharmaceutically acceptable salts of formula (I):
which are useful in the treatment of metabolic disorders related to insulin resistance or hyperglycemia. These compounds include inhibitors of protein tyrosine phosphatase (PTP-1B) that are useful in the treatment of diabetes and other PTP-1B mediated diseases, such as cancer, neurodegenerative diseases and the like. The compounds of the invention are also useful in pharmaceutical compositions and methods of treating the aforementioned conditions.
本发明涉及公式(I)化合物及其药学上可接受的盐,用于治疗与胰岛素抵抗或高血糖有关的代谢性疾病。这些化合物包括蛋白酪氨酸磷酸酶(PTP-1B)的抑制剂,可用于治疗糖尿病和其他PTP-1B介导的疾病,如癌症、神经退行性疾病等。本发明的化合物也适用于制药组合物和治疗上述疾病的方法。